OpenAI says it's adding Orchestra's team and technology to work on Rosalind, its AI model for life sciences research, and to its related Rosalind Workbench tool, a harness that aims to help researchers plan experiments and analyze results.
OpenAI acquires startup Orchestra Bio to beef up its biotech business
TE TechCrunch 
Key takeaways
OpenAI acquired biotech startup Orchestra Bio to enhance its life sciences AI tools.
- OpenAI announced the acquisition of Orchestra Bio, an AI biotech startup.
- Orchestra Bio's AI agents help manage drug discovery operations.
- OpenAI plans to integrate Orchestra's tech into its Rosalind AI model and tools.
Summarised automatically by AI from the original article by TechCrunch. AI can make mistakes, so check the original for details.
Read the full story on TechCrunch You've read the opening, about 38 of 198 words. The full piece is published by TechCrunch.
Continue reading ↗ Story details
- Published
- By
- Julie Bort
- Section
- AI
- Length
- 198 words · about 1 min read
- Format
- Article
- Original
- techcrunch.com ↗
